SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,303 | -99.5% | 2,173 | -98.9% | 0.00% | -100.0% |
| Q2 2023 | $246,891 | +314.1% | 189,916 | +460.7% | 0.00% | – |
| Q1 2023 | $59,618 | -94.4% | 33,874 | -84.5% | 0.00% | -100.0% |
| Q3 2022 | $1,070,000 | -39.5% | 218,429 | -48.9% | 0.01% | -45.5% |
| Q2 2022 | $1,769,000 | +414.2% | 427,274 | +622.7% | 0.01% | +266.7% |
| Q1 2022 | $344,000 | -72.5% | 59,123 | -64.5% | 0.00% | -75.0% |
| Q4 2021 | $1,251,000 | +112.4% | 166,748 | +155.2% | 0.01% | +71.4% |
| Q3 2021 | $589,000 | -38.8% | 65,344 | -18.8% | 0.01% | -36.4% |
| Q2 2021 | $963,000 | +200.9% | 80,454 | +214.8% | 0.01% | +175.0% |
| Q1 2021 | $320,000 | -85.3% | 25,555 | -81.6% | 0.00% | -86.7% |
| Q4 2020 | $2,171,000 | +155.7% | 139,098 | +54.9% | 0.03% | +130.8% |
| Q3 2020 | $849,000 | -23.9% | 89,806 | -27.9% | 0.01% | -31.6% |
| Q2 2020 | $1,116,000 | +466.5% | 124,526 | +302.0% | 0.02% | +280.0% |
| Q1 2020 | $197,000 | -76.1% | 30,974 | -68.5% | 0.01% | -66.7% |
| Q4 2019 | $824,000 | +11.7% | 98,400 | +43.7% | 0.02% | +7.1% |
| Q2 2019 | $738,000 | +45.3% | 68,478 | +28.5% | 0.01% | -12.5% |
| Q1 2019 | $508,000 | +167.4% | 53,273 | +222.1% | 0.02% | +77.8% |
| Q4 2018 | $190,000 | -84.6% | 16,538 | -74.6% | 0.01% | -87.5% |
| Q1 2018 | $1,237,000 | +239.8% | 65,087 | +193.6% | 0.07% | +278.9% |
| Q4 2017 | $364,000 | +21.7% | 22,170 | +11.2% | 0.02% | +11.8% |
| Q3 2017 | $299,000 | +315.3% | 19,942 | +143.9% | 0.02% | +240.0% |
| Q2 2017 | $72,000 | +380.0% | 8,176 | +229.4% | 0.01% | +400.0% |
| Q1 2016 | $15,000 | -54.5% | 2,482 | -31.9% | 0.00% | -50.0% |
| Q4 2015 | $33,000 | +50.0% | 3,646 | -7.1% | 0.00% | +100.0% |
| Q3 2015 | $22,000 | -73.5% | 3,924 | -47.7% | 0.00% | -75.0% |
| Q2 2015 | $83,000 | +4050.0% | 7,502 | +5457.0% | 0.00% | – |
| Q1 2015 | $2,000 | -95.5% | 135 | -95.3% | 0.00% | -100.0% |
| Q4 2014 | $44,000 | -81.8% | 2,885 | -87.1% | 0.00% | -86.7% |
| Q3 2014 | $242,000 | +60.3% | 22,431 | +126.6% | 0.02% | +66.7% |
| Q2 2014 | $151,000 | – | 9,897 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |